SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
NYSE New York Stock Exchange
Börse NYSE New York Stock Exchange
ISIN DE0005227201
USD
  • Biotest
    Börse NYSE New York Stock Exchange
    ISIN DE0005227201 WKN: 522720
    Symbol BIO
    USD
  • Bio-Rad Laboratories
    Börse NYSE New York Stock Exchange
    ISIN US0905722072 WKN: 865406
    Symbol BIO-B
  • Bio-Rad Laboratories
    Börse NYSE New York Stock Exchange
    ISIN US0905722072 WKN: 865406
    Symbol BIO
  • Bio-Rad Laboratories
    Börse Xetra Frankfurt
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Börse München
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Börse Stuttgart
    Symbol BIO
    EUR
  • BIO-RAD LABORATORIES-A
    Börse Börse Stuttgart
    Symbol BUWA
    EUR
  • BIO-RAD LABORATORIES-A
    Börse Börse Frankfurt
    Symbol BUWA
    EUR
  • BIO-RAD LABORATORIES-A
    Börse Börse München
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Gettex System der Börse München
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Quotrix System der Börse Düsseldorf
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Börse Düsseldorf
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Börse Düsseldorf
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Börse Hamburg
    Symbol BIO
    EUR
  • Bio-Rad Laboratories
    Börse Gettex System der Börse München
    Symbol BIO
    EUR
  • BIO-RAD LABORATORIES-A
    Börse Börse Berlin
    Symbol BUWA
    EUR
  • Bio-Rad Laboratories
    Börse Xetra Frankfurt
  • ISIN DE0005227235 WKN: 522723
    Symbol BIO3
    EUR
  • ISIN US0905722072
    Symbol BUWA
  • ISIN DE0005227201 WKN: 522720
    Symbol BIO
  • EUR
  • Symbol BIO
ISIN DE0005227201
WKN 522720
Symbol BIO
Währung USD
Börse NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Marktkapitalisierung 15.939.497.184 (+- 11%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

17.719.994.368 oder 14.159.000.000

Mitarbeiter 7.900 (+- 1%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

8.000 oder 7.800 Mitarbeiter

KGV 5.06
EBITDA 459.620.000
PEGRatio 1.0996
Buchwert 295.843

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 675 EUR -2,87% 

Aktionärsstruktur der Bio-Rad Laboratories, Inc

125 News & Informationen zur Bio-Rad Laboratories Aktie

  • Global Thyroid Cancer Diagnostics Market Gaining Momentum—Projected to Reach USD 3.6 Billion by 2027 | BlueWeave
    globenewswire.com

    Global Thyroid Cancer Diagnostics Market Gaining Momentum—Projected to Reach USD 3.6 Billion by 2027 | BlueWeave

    Global Thyroid Cancer Diagnostics Market Gaining Momentum—Projected to Reach USD 3.6 Billion by 2027…

  • Stocks That Hit 52-Week Highs On Monday
    benzinga.com

    Stocks That Hit 52-Week Highs On Monday

    Before 10 a.m. ET on Monday, 119 companies hit new 52-week highs.
    Noteables: The largest company by market cap to set a new 52-week high was …

  • Global High Throughput Screening (HTS) Markets Report 2021-2027 - Lab-on-a-Chip HTS Seeks to Proliferate the Market
    prnewswire.com

    Global High Throughput Screening (HTS) Markets Report 2021-2027 – Lab-on-a-Chip HTS Seeks to Proliferate the Market

    /PRNewswire/ — The

  • Global High Throughput Screening (HTS) Markets Report 2021-2027 - Lab-on-a-Chip HTS Seeks To Proliferate The Market
    thestreet.com

    Global High Throughput Screening (HTS) Markets Report 2021-2027 – Lab-on-a-Chip HTS Seeks To Proliferate The Market

    DUBLIN, Aug. 19, 2021 /PRNewswire/ — The “High Throughput Screening (HTS) – Global Market Trajectory & Analytics” report has been added to

  • Lateral Flow Assays Market Size is Expected to Reach $13.35 Billion by 2030: Says AMR
    globenewswire.com

    Lateral Flow Assays Market Size is Expected to Reach $13.35 Billion by 2030: Says AMR

    Lateral Flow Assays Market by Technique (Sandwich Assays, Competitive Assays, and Multiplex Detection Assays), Product (Kits & Reagents and Lateral Flow…

  • Tikvah Management LLC Buys Bio-Rad Laboratories Inc, Fifth Wall Acquisition Corp I, Sells Bio-Rad Laboratories Inc, QAD Inc, Berkshire...
    gurufocus.com

    Tikvah Management LLC Buys Bio-Rad Laboratories Inc, Fifth Wall Acquisition Corp I, Sells Bio-Rad Laboratories Inc, QAD Inc, Berkshire Hathaway Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Urinalysis Market worth $4.9 billion by 2026 - Exclusive Report by MarketsandMarkets™
    prnewswire.com

    Urinalysis Market worth $4.9 billion by 2026 – Exclusive Report by MarketsandMarkets™

    /PRNewswire/ — According to the new market research report “Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables,…

  • Global Neurodiagnostics Market Size to Surpass $12.89 Billion by 2030; IVD segment Would Cite the Fastest CAGR of 7.8%
    globenewswire.com

    Global Neurodiagnostics Market Size to Surpass $12.89 Billion by 2030; IVD segment Would Cite the Fastest CAGR of 7.8%

    Rise in prevalence of neurological disorders, increase in geriatric population, and technological advancements in neurodiagnostics drive the growth of the…

  • Global Rheumatoid Arthritis Diagnosis Tests Market To Reach $766.7 Million By 2026
    thestreet.com

    Global Rheumatoid Arthritis Diagnosis Tests Market To Reach $766.7 Million By 2026

    SAN FRANCISCO, Aug. 17, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra...
    news.google.com

    The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-

  • Stocks That Hit 52-Week Highs On Monday
    benzinga.com

    Stocks That Hit 52-Week Highs On Monday

    Before 10 a.m. ET on Monday, 71 companies hit new 52-week highs.
    Highlights: Apple (NASDAQ:AAPL) was the largest firm on a market cap basis to …

  • Global Life Science Tools Markets, 2017-2020 & 2021-2028 - Rise in the Number of Strategic Deals & Developments
    prnewswire.com

    Global Life Science Tools Markets, 2017-2020 & 2021-2028 – Rise in the Number of Strategic Deals & Developments

    /PRNewswire/ — The “Life Science Tools Market Size, Share & Trends Analysis Report by Technology (Cell Biology, Genomics), by Product (Flow Cytometry, Mass…

  • Global Chromatography Accessories and Consumables Market to Reach $12.9 Billion by 2024
    prnewswire.com

    Global Chromatography Accessories and Consumables Market to Reach $12.9 Billion by 2024

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
    markets.businessinsider.com

    The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…

  • Bio-Rad Laboratories: Surging Growth Continues
    gurufocus.com

    Bio-Rad Laboratories: Surging Growth Continues

    GuruFocus Article or News written by Robert Abbott and the topic is about: The share price may be undervalued, even though it has been driven higher by exceptional Ebitda and EPS growth

  • Global COVID-19 Rapid Diagnostic Test Market to Surpass US$ 7,660.2 Million by 2028, Says Coherent Market Insights (CMI)
    globenewswire.com

    Global COVID-19 Rapid Diagnostic Test Market to Surpass US$ 7,660.2 Million by 2028, Says Coherent Market Insights (CMI)

    SEATTLE, Aug. 12, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global COVID-19 rapid diagnostic test market is estimated to be…

  • Genomics Market to Register USD 21.10 bn growth during 2020-2024
    markets.businessinsider.com

    Genomics Market to Register USD 21.10 bn growth during 2020-2024

    NEW YORK, Aug. 11, 2021 /PRNewswire/ — As per Technavio's Research Analysis, the genomics market is likely to register a CAGR of over 15% while r…

  • Genomics Market To Register USD 21.10 Bn Growth During 2020-2024|Technavio
    thestreet.com

    Genomics Market To Register USD 21.10 Bn Growth During 2020-2024|Technavio

    NEW YORK, Aug. 11, 2021 /PRNewswire/ — As per Technavio's Research Analysis, the genomics market is likely to register a CAGR of over 15% while registering an

  • Insights on the Molecular Quality Controls Global Market to 2028 - by Product, Analyte Type, Application, End-user and Geography
    prnewswire.com

    Insights on the Molecular Quality Controls Global Market to 2028 – by Product, Analyte Type, Application, End-user and Geography

    /PRNewswire/ — The “Molecular Quality Controls Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Product, Analyte Type, Application, and End…

  • Codex DNA Reports Second Quarter 2021 Financial Results
    globenewswire.com

    Codex DNA Reports Second Quarter 2021 Financial Results

    SAN DIEGO, Aug. 10, 2021 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today reported…

  • Worldwide Custom Antibody Industry To 2028 - Proliferation Of Biotechnology Industry In Developing Regions Presents Opportunities
    thestreet.com

    Worldwide Custom Antibody Industry To 2028 – Proliferation Of Biotechnology Industry In Developing Regions Presents Opportunities

    DUBLIN, Aug. 10, 2021 /PRNewswire/ — The “Custom Antibody Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Service, Type, Source, and Research

  • Global Clinical Microbiology Instruments and Reagents Market to Reach $5.8 Billion by 2026
    prnewswire.com

    Global Clinical Microbiology Instruments and Reagents Market to Reach $5.8 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Glutathione Resin Market Size Worth $777.46 Million By 2028 | CAGR: 8.4%: Grand View Research, Inc.
    prnewswire.com

    Glutathione Resin Market Size Worth $777.46 Million By 2028 | CAGR: 8.4%: Grand View Research, Inc.

    /PRNewswire/ — The global glutathione resin market size is expected to reach USD 777.46 million by 2028, registering a CAGR of 8.4% over the forecast period,…

  • Global $3.49 Bn Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026
    prnewswire.com

    Global $3.49 Bn Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026

    /PRNewswire/ — The “Global Proteomics Market – Analysis By Component (Instruments, Reagents, Services), Application (Clinical Diagnostic, Drug Discovery,…

  • Global $3.49 Bn Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026
    thestreet.com

    Global $3.49 Bn Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026

    DUBLIN, Aug. 9, 2021 /PRNewswire/ — The “Global Proteomics Market – Analysis By Component (Instruments, Reagents, Services), Application (Clinical Diagnostic,

  • Europe Immunoassay Analyzers Market Report 2021-2028 - Increase in Research Activities in Biotech and Pharma Industries
    markets.businessinsider.com

    Europe Immunoassay Analyzers Market Report 2021-2028 – Increase in Research Activities in Biotech and Pharma Industries

    DUBLIN, Aug. 6, 2021 /PRNewswire/ — The 'Europe Immunoassay Analyzers Market Size, Share & Trends Analysis Report by Analyzers (Enzyme Immunoassa…

  • Profit per employee: Which are the most efficient companies in the S&P 500
    newacademyoffinance.com

    Profit per employee: Which are the most efficient companies in the S&P 500

    While most companies measure their success primarily by the amount of revenue or profit, they generate, to get an even better idea of these companies’

  • Global Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026 - Increasing Demand For Personalized Medicine To Bode Well For Market...
    thestreet.com

    Global Proteomics Market Analysis & Forecasts, 2016-2020 & 2021-2026 – Increasing Demand For Personalized Medicine To Bode Well For Market Growth

    DUBLIN, Aug. 4, 2021 /PRNewswire/ — The “Global Proteomics Market, By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery,

  • Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
    asiaone.com

    Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors

    Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors

    GlobeNewswire

    August 03, 2021

    LOWELL, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release…

  • Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
    globenewswire.com

    Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors

    LOWELL, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) — Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro”), an innovative life sciences technology…

  • Intermede Investment Partners Ltd Buys Diversey Holdings, Bio-Rad Laboratories Inc, HDFC Bank, Sells Ecolab Inc
    gurufocus.com

    Intermede Investment Partners Ltd Buys Diversey Holdings, Bio-Rad Laboratories Inc, HDFC Bank, Sells Ecolab Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Global Biosensors Market Size & Share Expected to Reach USD 34.08 Billion by 2026 Facts & Factors
    globenewswire.com

    Global Biosensors Market Size & Share Expected to Reach USD 34.08 Billion by 2026 Facts & Factors

    [225+ Pages Research Report] According to Facts and Factors market research report, the Global Biosensors Market size & share revenue is expected to grow…

  • Bio-Rad Laboratories, inc (BIO) Q2 2021 Earnings Call Transcript
    fool.com

    Bio-Rad Laboratories, inc (BIO) Q2 2021 Earnings Call Transcript

    BIO earnings call for the period ending June 30, 2021.

  • Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q2 2021 Results - Earnings Call Transcript
    seekingalpha.com

    Bio-Rad Laboratories, Inc. (BIO) CEO Norman Schwartz on Q2 2021 Results – Earnings Call Transcript

    Bio-Rad Laboratories, Inc. (NYSE:BIO) Q2 2021 Earnings Conference Call July 29, 2021, 06:00 PM ET Company Participants Edward Chung – Head of IR Norman Schwartz – CEO Ilan Daskal – EVP and…

  • Bio Rad Laboratories : Rad Reports Second-Quarter 2021 Financial Results (Form 8-K)
    marketscreener.com

    Bio Rad Laboratories : Rad Reports Second-Quarter 2021 Financial Results (Form 8-K)

    Bio-Rad Reports Second-Quarter 2021 Financial Results

    HERCULES, Calif.-July 29, 2021-Bio-Rad Laboratories, Inc. , a global leader of life science research and… | July 29, 2021

  • Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates
    zacks.com

    Bio-Rad Laboratories (BIO) Q2 Earnings and Revenues Beat Estimates

    Bio-Rad (BIO) delivered earnings and revenue surprises of 86.32% and 17.29%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Stocks That Hit 52-Week Highs On Thursday
    benzinga.com

    Stocks That Hit 52-Week Highs On Thursday

    Thursday's morning session saw 167 companies set new 52-week highs.
    Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by …

  • Global Size of Food Traceability Market Expected to Reach USD 24,406.80 Million by 2026: Facts & Factors
    globenewswire.com

    Global Size of Food Traceability Market Expected to Reach USD 24,406.80 Million by 2026: Facts & Factors

    [225+ Pages Research Report] According to Facts and Factors market research report, the Global Food Traceability Market size & share revenue is expected to…

  • Bio-Rad And 10x Genomics Announce Settlement To Resolve Multiple Litigations
    thestreet.com

    Bio-Rad And 10x Genomics Announce Settlement To Resolve Multiple Litigations

    Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that Bio-Rad and 10x

  • Stocks That Hit 52-Week Highs On Tuesday
    benzinga.com

    Stocks That Hit 52-Week Highs On Tuesday

    This morning 85 companies set new 52-week highs.
    Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Alphabet …

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Bio-Rad Laboratories Aktie

Das Unternehmen Bio-Rad Laboratories, Inc aus USA beschäftigt 7.900 Mitarbeiter und ist in den Bereichen Chemie & Pharma, LifeScience, Medizinische Produkte / Medizintechnik, Gerätehersteller, Biotechnologie, Pharma tätig.

Das Unternehmen Bio-Rad Laboratories, Inc ist in mehr als 45 ETFs enthalten und somit eine vermutlich durchschnittlich bekannte Aktie. Der Spitzenreiter iShares Healthcare Innovation  UCITS  ETF gewichtet Bio-Rad Laboratories mit 1,13% im ETF.

Entdecke die 6 ETFs in denen Bio-Rad Laboratories, Inc am höchsten gewichtet ist Insgesamt in 45 ETFs enthalten

Dir gefallen die Informationen zu Bio-Rad Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Bio-Rad Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Bio-Rad Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Bio-Rad Laboratories?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect